Travellers’ adherence to atovaquone/proguanil malaria chemoprophylaxis after return from endemic areas
Background: According to current guidelines, atovaquone/proguanil (AP) malaria chemoprophylaxis is taken once daily during travel, and continued for seven days after return from malaria-endemic areas. However, pharmacokinetic data and studies on drug-sparing AP regimens suggest that AP could possibl...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2025-03-01
|
| Serija: | Travel Medicine and Infectious Disease |
| Teme: | |
| Online dostop: | http://www.sciencedirect.com/science/article/pii/S1477893925000183 |
| Oznake: |
Brez oznak, prvi označite!
|